Literature DB >> 6815305

Thyrotrophin-releasing hormone analogues increase dopamine release from slices of rat brain.

T Sharp, G W Bennett, C A Marsden.   

Abstract

Rat brain slices were incubated with a high concentration of K+, thyrotrophin-releasing hormone (TRH), or one of two biologically stable TRH analogues (CG 3509 or RX 77368). Basal release of endogenous dopamine, measured by electrochemical detection, was increased by K+ (30 mM) from slices of hypothalamus, septum, nucleus accumbens, and striatum. CG 3509 (10-(5) -10-(3) M) increased the release of dopamine from slices of nucleus accumbens, septum, and hypothalamus in a dose-dependent fashion, whereas RX 77368 (10-(4) M) increased the release of dopamine from the septum only. Neither analogue increased the release of striatal dopamine. The results provide further evidence for specific regional interactions between TRH and dopamine in rat brain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815305     DOI: 10.1111/j.1471-4159.1982.tb08018.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat.

Authors:  F Crespi; P E Keane; M Morre
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

2.  Changes in the behavioural response to a TRH analogue following chronic amitriptyline treatment and repeated electroconvulsive shock in the rat.

Authors:  G W Bennett; A R Green; C Lighton; C A Marsden
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

3.  Recent advances in the treatment of narcolepsy.

Authors:  Nobuhide Hirai; Seiji Nishino
Journal:  Curr Treat Options Neurol       Date:  2011-10       Impact factor: 3.598

4.  Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.

Authors:  S Nishino; J Arrigoni; J Shelton; T Kanbayashi; W C Dement; E Mignot
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

5.  Intracerebroventricular injection of a TRH analogue, gamma-butyrolactone-gamma-carbonyl-L-histidyl-prolinamide, induces gastric lesions and gastric acid stimulation in rats.

Authors:  M Maeda-Hagiwara; H Watanabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.